NM_022082.4:c.316G>A

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_022082.4(SLC17A9):​c.316G>A​(p.Val106Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000239 in 1,609,548 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00014 ( 1 hom. )

Consequence

SLC17A9
NM_022082.4 missense

Scores

19

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.298

Publications

0 publications found
Variant links:
Genes affected
SLC17A9 (HGNC:16192): (solute carrier family 17 member 9) This gene encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. The encoded protein participates in the vesicular uptake, storage, and secretion of adenoside triphosphate (ATP) and other nucleotides. A mutation in this gene was found in individuals with autosomal dominant disseminated superficial actinic porokeratosis-8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
SLC17A9 Gene-Disease associations (from GenCC):
  • disseminated superficial actinic porokeratosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • porokeratosis 8, disseminated superficial actinic type
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006943941).
BP6
Variant 20-62957499-G-A is Benign according to our data. Variant chr20-62957499-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3040082.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 187 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC17A9NM_022082.4 linkc.316G>A p.Val106Ile missense_variant Exon 3 of 13 ENST00000370351.9 NP_071365.4 Q9BYT1-1
SLC17A9NM_001302643.2 linkc.298G>A p.Val100Ile missense_variant Exon 4 of 14 NP_001289572.2 Q9BYT1-2H0UI90
SLC17A9XR_936601.4 linkn.438G>A non_coding_transcript_exon_variant Exon 3 of 10
SLC17A9XM_011528978.3 linkc.-45G>A 5_prime_UTR_variant Exon 2 of 12 XP_011527280.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC17A9ENST00000370351.9 linkc.316G>A p.Val106Ile missense_variant Exon 3 of 13 1 NM_022082.4 ENSP00000359376.4 Q9BYT1-1
SLC17A9ENST00000370349.7 linkc.298G>A p.Val100Ile missense_variant Exon 4 of 14 1 ENSP00000359374.3 Q9BYT1-2
SLC17A9ENST00000411611.1 linkc.376G>A p.Val126Ile missense_variant Exon 3 of 3 2 ENSP00000388215.1 Q5W197
SLC17A9ENST00000488738.5 linkn.436G>A non_coding_transcript_exon_variant Exon 3 of 11 2

Frequencies

GnomAD3 genomes
AF:
0.00123
AC:
187
AN:
152142
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00425
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000344
AC:
84
AN:
244438
AF XY:
0.000263
show subpopulations
Gnomad AFR exome
AF:
0.00484
Gnomad AMR exome
AF:
0.000239
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000135
AC:
197
AN:
1457288
Hom.:
1
Cov.:
34
AF XY:
0.000130
AC XY:
94
AN XY:
725018
show subpopulations
African (AFR)
AF:
0.00456
AC:
152
AN:
33360
American (AMR)
AF:
0.000343
AC:
15
AN:
43738
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25992
East Asian (EAS)
AF:
0.0000765
AC:
3
AN:
39224
South Asian (SAS)
AF:
0.0000700
AC:
6
AN:
85730
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52674
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
0.00000450
AC:
5
AN:
1110672
Other (OTH)
AF:
0.000266
AC:
16
AN:
60140
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00123
AC:
187
AN:
152260
Hom.:
1
Cov.:
33
AF XY:
0.00126
AC XY:
94
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.00424
AC:
176
AN:
41546
American (AMR)
AF:
0.000392
AC:
6
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67998
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000742
Hom.:
0
Bravo
AF:
0.00150
ESP6500AA
AF:
0.00326
AC:
14
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000429
AC:
52

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

SLC17A9-related disorder Benign:1
Sep 27, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC17A9: BP4, BS1 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.75
DANN
Benign
0.55
DEOGEN2
Benign
0.066
T;.;.
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.53
T;T;T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.0069
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.16
N;.;.
PhyloP100
0.30
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.26
N;N;N
REVEL
Benign
0.020
Sift
Benign
0.39
T;T;T
Sift4G
Benign
0.49
T;T;T
Polyphen
0.0020
B;B;.
Vest4
0.15
MVP
0.030
MPC
0.35
ClinPred
0.0020
T
GERP RS
-0.99
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.013
gMVP
0.075
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201271567; hg19: chr20-61588851; COSMIC: COSV100947668; COSMIC: COSV100947668; API